Literature DB >> 1779614

Pristanic acid does not accumulate in peroxisomal acyl-CoA oxidase deficiency: evidence for a distinct peroxisomal pristanyl-CoA oxidase.

H J ten Brink1, B T Poll-The, J M Saudubray, R J Wanders, C Jakobs.   

Abstract

The concentration of pristanic acid was measured in plasma from a patient with an isolated peroxisomal very long chain fatty acid (VLCFA) acyl-CoA oxidase deficiency, a defect in peroxisomal beta-oxidation resulting in accumulation of VLCFA in plasma and tissues. Although peroxisomes are believed to be involved in pristanic acid beta-oxidation, the pristanic acid level in the patient's plasma was within the control range. This finding provides evidence for the existence of a pristanyl-CoA oxidase distinct from the specific trihydroxycholestanoyl-CoA and VLCFA acyl-CoA oxidases.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1779614     DOI: 10.1007/bf01799934

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  6 in total

1.  Pristanic acid and phytanic acid in plasma from patients with a single peroxisomal enzyme deficiency.

Authors:  H J ten Brink; R J Wanders; F Stellaard; R B Schutgens; C Jakobs
Journal:  J Inherit Metab Dis       Date:  1991       Impact factor: 4.982

2.  Identification of pristanoyl-CoA oxidase activity in human liver and its deficiency in the Zellweger syndrome.

Authors:  R J Wanders; H J ten Brink; C W van Roermund; R B Schutgens; J M Tager; C Jakobs
Journal:  Biochem Biophys Res Commun       Date:  1990-10-30       Impact factor: 3.575

3.  A comparative study of straight chain and branched chain fatty acid oxidation in skin fibroblasts from patients with peroxisomal disorders.

Authors:  H Singh; S Usher; D Johnson; A Poulos
Journal:  J Lipid Res       Date:  1990-02       Impact factor: 5.922

4.  Presence of three acyl-CoA oxidases in rat liver peroxisomes. An inducible fatty acyl-CoA oxidase, a noninducible fatty acyl-CoA oxidase, and a noninducible trihydroxycoprostanoyl-CoA oxidase.

Authors:  L Schepers; P P Van Veldhoven; M Casteels; H J Eyssen; G P Mannaerts
Journal:  J Biol Chem       Date:  1990-03-25       Impact factor: 5.157

5.  Accumulation of pristanic acid (2, 6, 10, 14 tetramethylpentadecanoic acid) in the plasma of patients with generalised peroxisomal dysfunction.

Authors:  A Poulos; P Sharp; A J Fellenberg; D W Johnson
Journal:  Eur J Pediatr       Date:  1988-02       Impact factor: 3.183

6.  A new peroxisomal disorder with enlarged peroxisomes and a specific deficiency of acyl-CoA oxidase (pseudo-neonatal adrenoleukodystrophy).

Authors:  B T Poll-The; F Roels; H Ogier; J Scotto; J Vamecq; R B Schutgens; R J Wanders; C W van Roermund; M J van Wijland; A W Schram
Journal:  Am J Hum Genet       Date:  1988-03       Impact factor: 11.025

  6 in total
  2 in total

1.  D-3-hydroxyacyl-CoA dehydratase/D-3-hydroxyacyl-CoA dehydrogenase bifunctional protein deficiency: a newly identified peroxisomal disorder.

Authors:  Y Suzuki; L L Jiang; M Souri; S Miyazawa; S Fukuda; Z Zhang; M Une; N Shimozawa; N Kondo; T Orii; T Hashimoto
Journal:  Am J Hum Genet       Date:  1997-11       Impact factor: 11.025

2.  Oxidation of pristanic acid in fibroblasts and its application to the diagnosis of peroxisomal beta-oxidation defects.

Authors:  B C Paton; P C Sharp; D I Crane; A Poulos
Journal:  J Clin Invest       Date:  1996-02-01       Impact factor: 14.808

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.